The phase 3 NRG GU-005 trial did not show a DFS benefit for SBRT vs IMRT in intermediate-risk prostate cancer, but SBRT decreased rectal toxicity. Stereotactic body radiation therapy (SBRT) preserves ...
Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) to moderately hypofractionated intensity-modulated radiation therapy (MH-IMRT) for patients ...
Army Hospital R&R installed an advanced ring-gantry Linear Accelerator for precise radiotherapy, improving cancer care for ...
Olympus Corporation (Olympus), a global MedTech company committed to advancing endoscopy-enabled care, announced today it has signed a definitive agreement to acquire BioProtect Ltd. (BioProtect), a ...
Light Wave Reports on MSN
One in eight men get prostate cancer. The treatment just got shorter.
Approximately one in eight American men will be diagnosed with prostate cancer during their lifetime. For most of them, if ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...
Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research ...
A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results